4.7 Article

MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression

期刊

JOURNAL OF INVESTIGATIVE DERMATOLOGY
卷 138, 期 1, 页码 141-149

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jid.2017.05.038

关键词

-

资金

  1. National Cancer Institute of the National Institutes of Health [R21 CA191742, P01 CA025874, R01 CA076674]
  2. Alfred Marchionini Foundation
  3. Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  4. Melanoma Research Foundation
  5. Helmholtz Portfolio Theme Metabolic Dysfunction and Common Disease
  6. Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases, ICEMED
  7. Boehringer Ingelheim Fonds
  8. MD fellowship
  9. Cancer Center Support Grant [CA010815]
  10. NATIONAL CANCER INSTITUTE [R01CA076674, P30CA010815, R21CA191742, P01CA025874] Funding Source: NIH RePORTER
  11. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Melanoma cells share many biological properties with neural crest stem cells. Here we show that the homeodomain transcription factor MSX1, which is significantly correlated with melanoma disease progression, reprograms melanocytes and melanoma cells toward a neural crest precursor-like state. MSX1-reprogrammed normal human melanocytes express the neural crest marker p75 and become multipotent. MSX1 induces a phenotypic switch in melanoma, which is characterized by an oncogenic transition from an E-cadherine-high nonmigratory state toward a ZEB1-high invasive state. ZEB1 up-regulation is responsible for the MSX1-induced migratory phenotype in melanoma cells. Depletion of MSX1 significantly inhibits melanoma metastasis in vivo. These results show that neural crest-like reprogramming achieved by a single factor is a critical process for melanoma progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据